Alvotech ALVO
NASDAQ ALVO
$5.00 -0.13 (-2.53%)
As of: Oct 22, 2026 · 10:49 AM EDT

Alvotech (ALVO) Preferred Stock Liabilities (2021)

Updated

Alvotech (ALVO) recorded Preferred Stock Liabilities of $250 million in Q4 2021.

Analysis

Alvotech (ALVO) Preferred Stock Liabilities (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,162.99 Bn 1,131.58 Bn 19.71 Bn -
2 Johnson & Johnson 633.71 Bn 552.23 Bn 17.26 Bn -
3 AbbVie 502.40 Bn 475.51 Bn 12.70 Bn -
4 Merck 376.48 Bn 330.86 Bn 12.21 Bn -
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn -
6 Astrazeneca 267.02 Bn 240.70 Bn 12.86 Bn -
7 Amgen 240.85 Bn 196.25 Bn 7.24 Bn -
8 Gilead Sciences 193.39 Bn 167.58 Bn 6.22 Bn -
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -
10 Alvotech 1.45 Bn 1.02 Bn 2.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 250.00 Mn
API Access

Alvotech Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ALVO&period=max&api_key=YOUR_API_KEY